An update from 4DMedical Ltd ( (AU:4DX) ) is now available.
4DMedical Ltd reported a significant increase in revenue from ordinary activities, up 265% to $2,895,000 for the half-year ended December 31, 2024, compared to the same period in 2023. Despite the revenue growth, the company experienced a 23% increase in loss from ordinary activities after tax, amounting to $19,168,000, and a net loss of $12,575,000, down 15% from the previous year. These financial results highlight the company’s ongoing challenges in achieving profitability, despite its strong revenue performance.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, focusing on innovative imaging solutions. The company is known for its advanced respiratory imaging technology, which aims to improve patient outcomes and enhance the diagnostic capabilities of healthcare providers.
YTD Price Performance: -13.54%
Average Trading Volume: 936,042
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$171.9M
See more data about 4DX stock on TipRanks’ Stock Analysis page.